Advertisement

Topics

Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials

19:00 EST 12 Nov 2017 | BioSpace

This financing brings the total equity capital that the company has raised since its inception in 2015 to $227 million.

Original Article: Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement